Sasha Jovanovic
3 min read
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge.
The Morning Bull – US Market Morning Update Friday, Jul, 31 2026
US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.3% and Nasdaq-100 futures ahead roughly 0.5%. The focus is on the June US PCE price index, which is expected to dip 0.1% month on month, while the core reading is seen up 0.2%. That combination suggests the cost of living may be easing slowly but still sits above the Federal Reserve’s 2% goal. At the same time, second quarter US GDP is projected at 2.1% annualised, helped by consumer spending and AI related investment. The puzzle for investors is whether cooling inflation and steady growth are enough to justify current pricing in rate sensitive areas such as technology, small caps and real estate stocks.
If you are unsure which rate sensitive stocks still look reasonably priced as inflation cools, start with 89 resilient stocks with low risk scores.
Top Movers
-
Nebius Group (NBIS) surged 27.13% ahead of its upcoming Q2 2026 earnings release.
-
Bloom Energy (BE) jumped 26.49% after a series of analyst updates and raised 2026 revenue guidance.
-
Sandisk (SNDK) gained 25.99%.
Is Nebius Group still a smart investment or just hype? Read our most popular narrative and get all the answers you need.
Top Losers
-
Alnylam Pharmaceuticals (ALNY) fell 28.31% after quarterly guidance was narrowed and the full year product revenue target was reduced.
-
Fair Isaac (FICO) declined 17.01% as investors reacted to Q3 results and a sharply lower price target from RBC.
-
Tradeweb Markets (TW) fell 9.60% following its Q2 earnings update and recent share repurchase activity.
If you want a broader list of stocks that held up better during yesterday’s swings, start with 89 resilient stocks with low risk scores.
Look past the noise – uncover the top narrative that explains what truly matters for Fair Isaac’s long-term success.
On The Radar
Earnings from consumer staples, health care and energy sit alongside fresh US manufacturing data to guide sentiment into next week.
-
Consumer staples focus with Colgate-Palmolive (CL) and Church & Dwight (CHD) Q2 results on Friday, highlighting everyday spending resilience.
-
Health care spotlight as AbbVie (ABBV), Moderna (MRNA) and STERIS (STE) report or meet Friday, updating drug and medical demand trends.
-
Energy in view with Chevron (CVX) and ExxonMobil Holdings (XOM) Q2 results on Friday, clarifying cash flows and capital plans.
-
Asset manager earnings from Ares Management (ARES) and T. Rowe Price (TROW) on Friday, giving a read on fee revenue and flows.
-
Macro focus on US ISM Manufacturing PMI and ISM Manufacturing Employment Monday, shaping expectations for factory activity and hiring.
